Use of deoxyribose nicotinamide adenine dinucleotide to enhance the specificity of NAD.sup.+ -dependent ligation reactions
US5508179A · kind A · utility
8Cited by
0References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 1994 |
| Grant date | Apr 16, 1996 |
| Priority date | — |
| Expiry date | Mar 18, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/81
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
This invention provides methods and compounds relating to the use of deoxyribose nicotinamide adenine dinucleotide (dNAD.sup.+) analogues in NAD.sup.+ -dependent ligation reactions. The compounds and methods may be used in NAD.sup.+ -dependent ligation reactions generally, and to increase the specificity of NAD.sup.+ -dependent ligation reactions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.